You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新里程(002219.SZ):擬參設青島新里程醫療產業投資中心
格隆匯 12-11 18:15

格隆匯12月11日丨新里程(002219.SZ)公佈,為更好地強化新里程健康科技集團股份有限公司(以下簡稱“公司”或“新里程”)在既有業務領域的影響力,提高在醫療服務領域的發展和佈局能力,優化公司資本結構,增強公司的綜合競爭力,公司於2024年12月10日召開第六屆董事會第三十一次會議審議通過了《關於對外投資的議案》,同意公司全資子公司四川福慧醫藥有限責任公司(以下簡稱“福慧醫藥”)、四川永道醫療投資管理有限公司(以下簡稱“永道醫療”)與山東鐵路發展基金有限公司(以下簡稱“鐵路基金”)及山東歷晟投資有限公司(以下簡稱“山東歷晟”)共同投資設立青島新里程醫療產業投資中心(有限合夥)(以下簡稱“合夥企業”),並簽署《青島新里程醫療產業投資中心(有限合夥)合夥協議》《青島新里程醫療產業投資中心(有限合夥)合夥協議之補充協議》(以下合稱“《合夥協議》”);同意公司為合夥企業優先級有限合夥人鐵路基金的投資本金及收益提供回購及差額補足義務,並簽署《青島新里程醫療產業投資中心(有限合夥)回購及差額補足協議》(以下簡稱“《回購及差額補足協議》”,與《合夥協議》合稱“投資協議”)。合夥企業的出資額規模為32,202萬元人民幣。

待公司收購重慶新里程醫療管理有限公司(以下簡稱“重慶新里程”)100%股權交割完成後,合夥企業擬收購持有重慶新里程100%股權。合夥企業在其存續期間僅投資持股重慶新里程,不會投資其他項目。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account